2012 Hemostasis Gordon Research Conference and Gordon Research Seminar

2012止血戈登研究会议暨戈登研究研讨会

• 批准号: 8388646
• 负责人: Sriram Krishnaswamy
• 金额: $ 1.95万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-07-15 至 2013-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8388646
• 关键词: Achievement; Affect; Animal Model; Applied Research; Area; Basic Science; Biochemistry; Biology; Biotechnology; Blood Clot; Blood Platelets; Blood Vessels; Blood coagulation; Cardiovascular Diseases; Cessation of life; Clinical Research; Coagulation Process; Commit; Communities; Development; Diagnosis; Discipline; Disease; Ensure; Environment; Enzymatic Biochemistry; Equilibrium; Faculty; Fostering; Future; Genetic; Goals; Health; Hemorrhage; Hemostatic Agents; Hemostatic function; Human; Individual; Infection; Inflammation; International; Medical; Medicine; Membrane; Minority; Molecular Biology; Nature; Pharmacologic Substance; Physicians; Play; Postdoctoral Fellow; Process; Proteins; Receptor Signaling; Regulation; Research; Research Personnel; Role; Scientist; Series; Site; Students; Talents; Thrombosis; Thrombus; Training; Transgenic Animals; Travel; Woman; Work; abstracting; atherothrombosis; catalyst; cost; disability; experience; human disease; improved; innovation; interest; man; meetings; programs; social; structural biology; success; symposium; tool

DESCRIPTION (provided by applicant): We request partial support for a Gordon Research Conference and Gordon Research Seminar on Hemostasis. The proposed conference is to be held at the GRC site in Waterville Valley, NH, July 22-27, 2012. This conference in 2012 is the 31st such meeting since its inception in 1973 that is now being held biennially. The meeting in 2010 was approved to be held in conjunction with a 1 day Gordon Research Seminar dedicated to trainee presentations and to enhance their profile at the GRC. We are delighted to be again approved to hold the 1 day Gordon Research Seminar to precede the Hemostasis GRC in 2012. The Hemostasis Gordon Research Conference brings together scientists interested in the biology, biochemistry and genetics of platelets and coagulation proteins, physicians involved in the treatment of bleeding and thrombotic diseases and investigators from small and large pharmaceutical companies developing new therapies for hemostatic disorders. The conference has legendary status establishing it as the forum at which cutting-edge research is presented and major advances in the field are unveiled. Indeed, some of the most spectacular recent achievements in hemostasis have been first unveiled at previous conferences in this series or have been driven by collaborative interactions fostered by this conference. The roster of invited speakers and discussion leaders who have already agreed to participate is impressive and represents top investigators in the field. These attendees will enhance the stimulating nature of the environment for all attendees and especially junior investigators and trainees. Trainee participation in the meeting will be greatly enhanced by the popular Gordon Research Seminar. As in past conferences, we will endeavor to promote participation by women and minorities and facilitate attendance by junior faculty, students, postdoctoral fellows and individuals with physical disabilities. The program currently includes a Historical Perspective Session to begin the meeting on a lighter/general interest note and 8 sessions: 1. Inflammation/Infection and Coagulation; 2. Thrombus Formation and its Dissolution; 3. Defective Hemostasis; 4. Blood/Vessel Wall Interface; 5. Receptors and Signaling; 6. Hot Topic Abstract Talks; 7. Regulation of Thrombus Formation; 8. Membranes/Microparticles/ Atherothrombosis. PUBLIC HEALTH RELEVANCE: We request partial support for a Gordon Research Conference focused on normal blood coagulation as well as excessive bleeding and thrombosis prevalent in human disease. This is a cutting edge conference that brings together outstanding scientists doing research in the diverse facets that affect blood clotting. The meeting enjoys an international reputation for being the forum at which new advances in the field are unveiled.

描述（由申请人提供）：我们请求对戈登研究会议和戈登止血研究研讨会提供部分支持。拟议的会议将于2012年7月22日至27日在新罕布什尔州沃特维尔谷的GRC现场举行。2012年的这次会议是自1973年成立以来的第31次会议，现在每两年举行一次。2010年的会议被批准与为期1天的戈登研究研讨会一起举行，该研讨会专门用于培训生的演讲，并提高他们在GRC的形象。我们很高兴再次获得批准，在2012年止血GRC之前举办为期1天的Gordon研究研讨会。止血戈登研究会议汇集了对血小板和凝血蛋白的生物学、生物化学和遗传学感兴趣的科学家、参与治疗出血和血栓性疾病的医生以及来自开发止血疾病新疗法的小型和大型制药公司的研究人员。该会议具有传奇般的地位，使其成为展示前沿研究和揭示该领域重大进展的论坛。事实上，止血领域最近取得的一些最引人注目的成就在本系列的前几次会议上首次亮相，或者是由本次会议促进的合作互动推动的。受邀发言者和已同意参加讨论的领导人名单令人印象深刻，代表了该领域的顶级调查人员。这些与会者将提高所有与会者，特别是初级研究人员和学员的环境的刺激性。受欢迎的戈登研究研讨会将大大提高学员对会议的参与。与以往的会议一样，我们将奋进促进妇女和少数民族的参与，并促进初级教师、学生、博士后研究员和身体残疾者的出席。该计划目前包括一个历史的角度来看会议开始会议上一个打火机/一般的兴趣注意和8个会议：1。炎症/感染和凝血; 2.血栓形成及其溶解; 3.止血不良; 4.血液/血管壁界面; 5.信号传导和信号传导; 6。热门话题抽象会谈; 7.血栓形成的调节; 8.膜/微粒/动脉粥样硬化血栓形成。公共卫生关系：我们请求部分支持戈登研究会议，重点是正常的血液凝固以及人类疾病中普遍存在的过度出血和血栓形成。这是一个前沿会议，汇集了在影响血液凝固的各个方面进行研究的杰出科学家。该会议享有国际声誉，是该领域新进展的论坛。